Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Oct 2022 for Avenue Therapeutics, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
InvaGen Pharmaceuticals, Inc.: trading record in brief
One trade, one date: on 13 October 2022, InvaGen Pharmaceuticals, Inc. disclosed an open-market sale in Avenue Therapeutics, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to InvaGen Pharmaceuticals, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
388,888 shares@ €7.9524100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-22-108589:0
1 of 1 declaration
